{"first_name":"Ivan","last_name":"Bergstein","permalink":"ivan-bergstein","crunchbase_url":"http://www.crunchbase.com/person/ivan-bergstein","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Fri Jun 05 10:49:04 UTC 2009","updated_at":"Fri Jun 05 10:49:50 UTC 2009","overview":"<p>Prior to founding Stemline, Dr. Bergstein was Medical Director of Access Oncology, Inc. (now Keryx Biopharmaceuticals, Inc. [Nasdaq: KERX]) where he was a key member of the team that in-licensed and developed several clinical stage oncology compounds. Prior to this, he was senior biopharmaceuticals analyst at Cancer Advisors (now Nitron Advisors), a Wall Street-based firm that advises investment funds on public oncology-focused companies. He received a B.A. in mathematics from the University of Pennsylvania, an M.D. from the Mount Sinai Medical Center, and completed an internal medicine residency and hematology-medical oncology fellowship at the New York Presbyterian Hospital-Weill Medical College of Cornell University.</p>","image":null,"degrees":[],"relationships":[{"is_past":false,"title":"CEO","firm":{"name":"Stemline Therapeutics","permalink":"stemline-therapeutics","type_of_entity":"company","image":{"available_sizes":[[[101,40],"assets/images/resized/0004/6901/46901v1-max-150x150.png"],[[101,40],"assets/images/resized/0004/6901/46901v1-max-250x250.png"],[[101,40],"assets/images/resized/0004/6901/46901v1-max-450x450.png"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}